MSFHR funded COVID-19 research to mitigate effects on BC’s vulnerable populations
On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…
On Jun. 29, 2020, the Michael Smith Foundation for Health Research (MSFHR) COVID-19 Research Response Fund announced funding…
On Jun. 26, 2020, Vaxart announced that its oral COVID-19 vaccine has been selected to participate in a…
On Jun. 26, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $750,000 to Dr. Xiaokui Zhang at…
On Jun. 26, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
On Jun. 26, 2020, the COVID-19 Therapeutics Accelerator donors and partners announced the formation of the International COVID-19…
On Jun. 25, 2020, the University of Alberta (U of A) announced a study that will analyze thousands…
On Jun. 25, 2020, the World Health Organization (WHO) announced the end of the 10th outbreak of Ebola…
On Jun. 25, 2020, the Government of Canada announced the results of that funding competition: an investment of…
On Jun. 25, 2020, researchers at the University of British Columbia announced they had received a combined total…
On Jun. 25, 2020, Vaxart announced it had signed a Memorandum of Understanding with Attwill Medical Solutions Sterilflow,…
On Jun. 25, 2020 Moderna announced a collaboration for large-scale, commercial fill-finish manufacturing of Moderna’s mRNA-based COVID-19 vaccine…
On Jun. 25, 2020, LabCorp announced the launch of a new test that can be used to assess…
On Jun. 25, 2020, SIGA Technologies announced the deliveries of oral TPOXX (tecovirimat) to the U.S. Department of…
On Jun. 24, 2020, Sinovac Biotech announced the China National Medical Products Administration (NMPA) issued a product license…
On Jun. 24, 2020, Oncotelic, a wholly owned subsidiary of Mateon Therapeutics, announced that IBM has granted access…
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
On Jun. 24, 2020, RedHill Biopharma announced that results from the treatment of the first severe COVID-19 patients…
On Jun. 24, 2020, Howard Hughes Medical Institute (HHMI) investigators reported that data from COVID-19 cases around the…
On Jun. 24, 2020, Symbiosis Pharmaceutical Services, an India-based specialist provider of pharmaceutical and vaccine development services, announced…
On Jun. 24, 2020, the University of Oxford that the COVID-19 National DiagnOstic Research and Evaluation Platform (CONDOR)…
On Jun. 23, 2020, the National Institutes of Health (NIH) announced it had tested a ‘universal mosquito vaccine’…
On Jun. 23, 2020, more than 300 scientists and clinicians from the federal government, industry and academia published…
On Jun. 23, 2020, FibroGen announced it has started enrollment for a Phase II clinical trial of pamrevlumab…
On Jun. 23, 2020, Mateon Therapeutics, a leading developer of TGF-β therapeutics, announced it has selected IQVIA to…
On Jun. 23, 2020, scientists at Scripps Research reported that some common strains of influenza have the potential…
On Jun. 23, 2020, Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage…
On Jun. 23, 2020, INOVIO announced it had received $71 million funding from the U.S. Department of Defense…
On Jun. 22, 2020, Intravacc announced promising results of a preclinical study with its experimental whooping cough vaccine…
On Jun. 22, 2020, Catalent announced that it is partnering with ViralClear Pharmaceuticals, a subsidiary of BioSig Technologies,…
On Jun. 22, 2020, Pfizer announced the initiation of four phase 3 clinical trials within its current pipeline…